Breadcrumb Navigation:

Home > MS Clinical Care and Research Professionals > Researchers > Get Funding

Get Funding

The National MS Society has developed a strategic roadmap -- the Strategic Response: 2011-2015 -- that strives to be a response to the brutal facts of living with MS and identifies what must be done to achieve a world free of MS. Through this response we strive to be a driving force of MS research and treatment to stop disease progression, restore function, and end MS forever. The five research objectives outlined in the Strategic Response were developed through recommendations from our Research Programs Advisory Committee and other stakeholders in the community including researchers, physicians, and people with MS. These objectives are:

  • We better understand the mechanisms that lead to disease progression and we accelerate the development of new therapies.
  • We pursue new avenues to discover how nerve cells are damaged and potentially repaired.
  • We pursue new rehabilitation techniques and symptomatic treatments to restore neurological function and enhance quality of life.
  • We identify risk and triggering factors that cause MS, and understand the biological interactions that lead to its development so that MS can be prevented.
  • We expand and strengthen the quantity and quality of MS research worldwide to accelerate new discoveries and treatments for people with MS.

Going forward, we will be announcing program priorities, RFAs and other funding mechanisms to help us achieve these objectives. Some areas of interest include:

  • Immunologic basis of MS
  • CNS repair and neuroprotection
  • Biology of glia/myelin
  • Genetics and gender differences
  • Understanding and preventing disease progression
  • Infectious triggers and risk factors
  • Cognitive and psychosocial issues
  • Patient management, care and rehabilitation
  • Pathology of MS
  • Clinical trials
  • Health care delivery and policy
  • Measures of disease activity, imaging, surrogate and biomarkers

The Society also emphasizes industry partnerships by providing milestone-driven drug development funding to private companies. Read more about our Fast Forward initiative.

FUNDING OPPORTUNITIES